We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

In Vitro Maturation of Immature Oocytes

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00480337
First Posted: May 30, 2007
Last Update Posted: December 17, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sheba Medical Center
  Purpose
The aim of this study is to aspirate immature oocytes from antral follicles and mature the oocytes in vitro. These mature oocytes will serve for fertilization and the creation of embryos which will be replace in the uterus as performed during normal IVF.We will record the efficacy and safety of this procedure.

Condition Intervention
Polycystic Ovary Syndrome Ovarian Hyperstimulation Syndrome Procedure: In Vitro Maturation of immature oocytes

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Further study details as provided by Sheba Medical Center:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Women with PCOS
  • Women with previous Hyperstimulation or with risk of developing hyperstimulation during IVF Treatment
  • Women diagnosed with cancer who are interested in fertility preservation
  • Women with repeated IVF failure

Exclusion Criteria:

  • Severe cases of endometriosis
  • Large myomas
  • Hydrosalpinxs Technical problem with previous oocytes pick-up
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00480337


Locations
Israel
IVF Unit, Shea Medical Center, Tel-Hashomer
Ramat-Gan, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Ariel Hourvitz IVF Unit, Sheba Medical Center
  More Information

ClinicalTrials.gov Identifier: NCT00480337     History of Changes
Other Study ID Numbers: SHEBA-06-4317-AH-CTIL
First Submitted: May 29, 2007
First Posted: May 30, 2007
Last Update Posted: December 17, 2008
Last Verified: December 2008

Keywords provided by Sheba Medical Center:
PCOS
Fertility Preservation
Repeated IVF Failure
S/P Hyperstimulation

Additional relevant MeSH terms:
Syndrome
Polycystic Ovary Syndrome
Ovarian Hyperstimulation Syndrome
Disease
Pathologic Processes
Ovarian Cysts
Cysts
Neoplasms
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Gonadal Disorders
Endocrine System Diseases